← Insider buys
UTHR

United Therapeutics Corporation · Healthcare

Chair and CEO Martine A Rothblatt sold $5.5M of United Therapeutics Corporation

Sold$5,476,462
$576.47Price
9,500Shares
−3%Stake

What UTHR did after the filing

Filed Oct 2Copier in Oct 5
The stock from Mon, Oct 5 open, $540.41
+0.5%
S&P 500, same days
−0.4%

10 of 30 trading days so far, to the Oct 19 close.

Traded Thu, Oct 1. Filed Fri, Oct 2, 4:31 PM ET, after the close. Returns use the Oct 5 open and the Oct 19 close. Not investment advice.